<ROOT>
  <POLIDOC LABEL="CSA Staff Notice">
    <POLIDENT>
      <N></N>
      <TI>CSA Staff Notice 51-362
            

            
              Staff Review of COVID-19 Disclosures and Guide for Disclosure
Improvements</TI>
      <DATE></DATE>
    </POLIDENT>
    <FREEFORM>
      <BLOCK1>
        <TI></TI>
        <IMAGE></IMAGE>
      </BLOCK1>
      <BLOCK1>
        <TI>CSA Staff Notice 51-362
            

            
              Staff Review of COVID-19 Disclosures and Guide for Disclosure
Improvements</TI>
        <BLOCK2>
          <TI>February 25, 2021</TI>
        </BLOCK2>
      </BLOCK1>
      <BLOCK1>
        <TI>Introduction</TI>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The Canadian Securities Administrators (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CSA</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) have prepared this Staff Notice (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Notice</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) to report the
results of recently completed continuous disclosure reviews (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">reviews</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) conducted by CSA staff (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">staff or
we</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) of the disclosures provided by reporting issuers</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="6.40pt">
            <SUP>1</SUP>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">on the impact of COVID-19 to their business. Since
the World Health Organization declared COVID-19 as a pandemic on March 11, 2020, COVID-19 has
had a material adverse impact on the economy and is posing widespread business challenges for many
issuers, including reporting on and disclosing the business impact of COVID-19.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">This issue-oriented review assessed compliance of issuers’ disclosures of the current and anticipated
impacts related to COVID-19 on their respective operations, financial condition, liquidity and future
prospects. The reviews also assessed key financial reporting areas applicable to issuers that may be
subject to significant judgement and measurement uncertainty in the current environment.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">We recognize that issuers are preparing disclosure in a rapidly changing environment. However,
meaningful disclosures about the business impacts and potential uncertainties regarding COVID-19 are
needed for investors to make informed investment decisions. This Notice summarizes our key review
findings and includes some disclosure examples and guidance to assist reporting issuers and their advisors
with disclosing and reporting on the impact of COVID-19 to their business and operations.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">We will continue to closely monitor issuers’ continuous disclosure (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CD</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) filings in relation to the impact
of the COVID-19 pandemic as part of our ongoing CSA CD review program. For further details, see CSA
Staff Notice 51-312 (revised)</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>Harmonized Continuous Disclosure Review Program</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="6.40pt">
            <SUP>2</SUP>
          </FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>.</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">An issuer’s
disclosure relating to the impacts and risk factors of the COVID-19 pandemic may also be assessed as
part of staff’s review of prospectus filings in connection with public offerings.</FONT>
        </P>
        <FOOTNOTE>
          <FREEFORM>
            <P>
              <FONT font-name="Calibri" font-size="11.00pt">1</FONT>
              <FONT font-name="TimesNewRomanPSMT" font-size="9.00pt">In this Notice “issuers” means those reporting issuers contemplated in National Instrument 51-102</FONT>
              <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="9.00pt">
                <EM>Continuous Disclosure
Obligations</EM>
              </FONT>
              <FONT font-name="TimesNewRomanPSMT" font-size="9.00pt">(</FONT>
              <BOLD>
                <FONT font-name="TimesNewRomanPS-BoldMT" font-size="9.00pt">NI 51-102</FONT>
              </BOLD>
              <FONT font-name="TimesNewRomanPSMT" font-size="9.00pt">).</FONT>
            </P>
          </FREEFORM>
        </FOOTNOTE>
        <P>
          <FONT font-name="Calibri" font-size="11.00pt">2</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="9.00pt">Additional regulatory guidance on COVID-19 can be accessed at the CSA COVID-19 Information Hub at</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="9.00pt">https://www.securities-administrators.ca/aboutcsa.aspx?id=1885</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="9.00pt">.</FONT>
        </P>
      </BLOCK1>
      <BLOCK1>
        <TI>Contents of the Notice</TI>
        <BLOCK2 LABEL="Table">
          <TMPTABLE>
            <SGMLTBL>
              <TBLHEAD TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="16" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="9" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="67" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="8" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">Introduction....</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="3">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">...........................................................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="4">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">........1</FONT>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLHEAD>
              <TBLBODY TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="16" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="9" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="67" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="8" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">Part 1 - Executive Summary.....................................................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">........3</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">Part 2 - Scope and Methodology..............................................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">........3</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">Part 3 - Summary of Results and Key Themes.........................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">........5</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">Appendix A – Key Observations and Considerations..............................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">........8</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">A.1</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">MD&amp;A</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="3">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">Reporting</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="4">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">g..........................................................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="5">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">........8</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">A.2 Financial Statements......................................................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......13</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">A.3 Other Regulatory Matters..............................................................................................
Appendix B – Disclosure Examples.........................................................................................
B.1 MD&amp;A Disclosure Examples........................................................................................
B.1.1 Discussion of Operations and the Impact of COVID-19.........................................
B.1.2 Discussion of Strategies Related to COVID-19......................................................
B.1.3 Liquidity and Capital Resources..............................................................................
B.1.4 Risk Factor Disclosure.............................................................................................
B.2 Financial Statements Examples.....................................................................................
B.2.1 Impairment of Non-Financial Assets.......................................................................
B.2.2 Going Concern.........................................................................................................
B.2.3 Government Assistance...........................................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......18</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......21</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......21</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......21</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......22</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......22</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......23</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......24</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......24</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......25</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......26</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">B.3 Other Regulatory Matters Examples..............................................................................
B.3.1 Non-GAAP Financial Measures..............................................................................</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......27</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="12.00pt">......27</FONT>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLBODY>
            </SGMLTBL>
          </TMPTABLE>
        </BLOCK2>
      </BLOCK1>
      <BLOCK1>
        <TI>Part 1 - Executive Summary</TI>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The COVID-19 pandemic has significantly impacted the financial condition, financial performance,
operations and cash flows of reporting issuers of varying sizes and industries. This has specific financial
reporting implications for issuers.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">We were encouraged by the quality of disclosures provided by many issuers significantly impacted by
COVID-19. However, we noted certain areas where boiler-plate disclosure was provided regarding the
current and expected impact of COVID-19 on an issuer’s business with insufficient detail of entity-
specific COVID-19 related risks, including but not limited to, the nature and extent of credit risks and
liquidity uncertainties. We also observed instances of unbalanced or overly promotional disclosure and
isolated non-compliance for non-GAAP financial measures (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGM</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">s) and forward-looking information
(</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">). It is important for issuers to tailor their disclosures to provide investors with an entity-specific
level of insight to understand the operational challenges, financial impacts, risk profile and the issuer’s
operational responses related to the COVID-19 pandemic. Such information is necessary to meet
securities requirements and to help foster investor confidence in the current environment.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The reviews have resulted in outcomes where no action was required, requests for prospective disclosure
enhancements were made, or communication is ongoing to resolve the identified issues.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">At a high level, we emphasize the following for issuers to consider in their upcoming CD filings:</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">no one size f
ons of COVID-19</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Disclosures are ex ected to be trans arent and balanced</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Provide dis</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">on COVID-1</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">ansparen an a a
19 that facilitates an</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The current and expected impact of COVID-19 on the issuer’s operations and financial
condition, including liquidity and capital resources.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The key risks that the COVID-19 pandemic presents to the issuer.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Known trends, demands, events or uncertainties related to COVID-19 that management
reasonably believes will materially affect the issuer’s future revenues, expenses or
projects.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The operational changes and other measures taken by management in response to
COVID-19.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">How COVID-19 has impacted the issuer’s capacity to meet working capital
requirements, debt covenants, planned growth or funding of future development activities
and capital expenditures.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">How the COVID-19 pandemic has impacted areas of financial reporting subject to
significant judgement and measurement uncertainty in the current environment.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="11.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">How the issuer has assessed impairment of non-financial assets given the extended
impact of the COVID-19 pandemic. Where applicable, sensitivity analysis and
disclosures relating to key assumptions will be especially important and should be both
realistic and supportable.</FONT>
        </P>
        <P>
          <FONT font-name="CourierNewPSMT" font-size="12.00pt">o</FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">The accounting policy for, and nature and extent of government grants recognized in the
financial statements.</FONT>
        </P>
      </BLOCK1>
      <BLOCK1>
        <TI>Part 2 - Scope and Methodology</TI>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Staff took a risk-based approach in the selection of issuers by considering both qualitative and
quantitative criteria. Issuers selected for review included those identified as being materially impacted</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">(both positively and adversely) by the COVID-19 pandemic in terms of their operations and financial
performance, as well as issuers that appeared to have a higher risk of impairment and/or financial distress.</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Staff examined the CD filings of approximately 90 issuers, focusing on the disclosures of the most recent
interim reporting period ending September 30, 2020 for issuers with a calendar financial year end. The
issuers selected for review varied by size and by industry as illustrated in the charts below:</FONT>
        </P>
        <TEXT>
        
          Figure #1
        
      </TEXT>
        <IMAGE></IMAGE>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Our reviews primarily focused on issuers’ disclosure obligations under National Instrument 51-102</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>Continuous Disclosure Obligations</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">(</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NI 51-102</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">). We also assessed compliance with certain recognition,
measurement and disclosure requirements in International Financial Reporting Standards (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">IFRS</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) and
compliance with CSA Staff Notice 52-306</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>(Revised) – Non-GAAP Financial Measures</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">(</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">SN 52-306</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">). The
following outlines the focus areas of the reviews conducted:</FONT>
        </P>
      </BLOCK1>
      <BLOCK1>
        <TI>Part 3 - Summary of Results and Key Themes</TI>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Our reviews covered a variety of industries and highlighted the diverse impacts of the COVID-19
pandemic on issuers’ operations and businesses. Some of these impacts included:</FONT>
        </P>
        <IMAGE></IMAGE>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Issuers adjusted their operations in numerous ways to manage the impact of COVID-19 on their
operations and liquidity. Various measures/operational responses disclosed by issuers included:</FONT>
        </P>
        <IMAGE></IMAGE>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Most issuers reviewed were proactive in providing quality and detailed disclosures. For example, we
observed several issuers significantly expand their MD&amp;A to provide detailed operational updates
addressing the impact of COVID-19 as well as issuers providing additional disclosure addressing debt
covenants and related compliance. We also noted most issuers adequately disclosed impairments of non-</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">financial assets due to a deterioration in their business since the onset of the pandemic. However, we
identified several areas where disclosure could be improved for many issuers including the following:</FONT>
        </P>
        <BLOCK2 LABEL="Table">
          <TMPTABLE>
            <SGMLTBL>
              <TBLHEAD TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="26" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="74" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Area of Disclosure</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Key Observations</FONT>
                      </BOLD>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLHEAD>
              <TBLBODY TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="26" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="74" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">MD&amp;A</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Discussion of measures taken to reduce COVID-19 impact</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">-
Many issuers provided “lists” of measures employed to manage
operational and liquidity risks but did not provide an adequate
discussion to address the anticipated impact to the issuer.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Analysis of overall performance and operations</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Most issuers
that quantitatively disclosed variances related to COVID-19 (e.g.,
impact to sales) did not explain the methodology used by
management in determining that fluctuations were isolated to
COVID-19.
 Several issuers provided limited disclosure of known trends or
events related to COVID-19 that are likely to affect future
performance.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Liquidity and capital resources</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Many issuers with material
liquidity risks did not disclose in detail their ability to meet
working capital requirements, planned growth initiatives or to fund
developmental activities and capital expenditures. Lack of
disclosure regarding trends or expected fluctuations in liquidity
taking into account events or uncertainties related to COVID-19
was commonly observed.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Risk factor disclosure</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Several issuers provided “lists” of risks
without discussion or general disclosures that touched on general
economic or societal impacts of COVID-19 and did not describe
entity-specific COVID-19-related risks.</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Financial Statements</FONT>
                      </BOLD>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">General</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers failed to adequately update their
disclosures and assumptions impacted by COVID-19 in the context
of testing impairments of goodwill and intangible assets,
measuring fair value (</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FV</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) and estimating expected credit losses.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Significant judgements and measurement uncertainties</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">– Some
issuers failed to include entity-specific disclosure for significant
judgements or measurement uncertainties or only included this
disclosure in their MD&amp;A but not in their financial statements.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Impairment of non-financial assets</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">– A few issuers did not
identify reasons for impairments or just noted “negative economic
impacts of COVID-19” as an impairment indicator for all cash
generating units (</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">CGU</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">s) but did not elaborate on those impacts.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Going concern</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers breached financial covenants
during the reporting period but did not disclose the implications of
breaches on the issuer's ability to continue as a going concern.
Some issuers disclosed “close call” situations but did not disclose
the mitigating actions that impacted their determination that there
were no material uncertainties that cast significant doubt on the
issuer’s ability to continue as a going concern (e.g. successful
negotiation of credit facilities subsequent to period end).</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Government assistance</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Over half of the issuers we reviewed
recognized, or disclosed in subsequent events, COVID-19 related
government assistance in their financial statements since the
outbreak of the COVID-19 pandemic. Some issuers did not
disclose the nature and extent of the government assistance or the</FONT>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLBODY>
            </SGMLTBL>
          </TMPTABLE>
        </BLOCK2>
        <BLOCK2 LABEL="Table">
          <TMPTABLE>
            <SGMLTBL>
              <TBLHEAD TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="30" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="70" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Area of Disclosure</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Key Observations</FONT>
                      </BOLD>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLHEAD>
              <TBLBODY TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="30" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="70" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">accounting policy adopted including the methods of presentation.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Expected credit losses (ECL)</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Only a few issuers disclosed the
use of COVID-19-induced adjustments/overlays to their ECL
models.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Financial Instrument Risk Disclosure -</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Some issuers that
experienced material adverse impacts of COVID-19 did not
provide an entity-specific update to their risk disclosure in the
financial statements.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">COVID-19 related amendments to IFRS 16</FONT>
                        <FONT font-name="TimesNewRomanPS-BoldItalicMT" font-size="11.00pt">
                          <EM>Leases</EM>
                        </FONT>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">for Lessees
–</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Certain issuers did not sufficiently disclose whether they applied
the practical expedient to either all or some of their rent
concessions.</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGMs</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">NGMs adjusted for COVID-19</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Most issuers did not present
NGMs that adjusted for the impact of COVID-19. However, our
review found isolated instances of potentially misleading NGMs in
relation to COVID-19 (e.g., adjusting for expenses attributable to
COVID-19 without adjusting for government subsidies or
“normalizing” revenue or expenses for the year-to-date period
based on more positive results for one quarter).</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">FLI related to COVID-19</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- In certain cases, we observed
insufficient disclosure of assumptions used to develop FLI and
failure to adequately update the MD&amp;A for events and risks that
could cause actual results for future periods to differ materially
from previously disclosed FLI.</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Material Change Reporting</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">If COVID-19 has an equal effect throughout an issuer’s industry, a
material change report may not be required. Only a few issuers
reviewed filed material change reports in relation to COVID-19
although in some instances changes to the issuer’s business, operations
or capital were more unique or more significant to them than to others
in their industry.</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Promotional Disclosures</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Potentially misleading disclosures</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">- Some issuers concentrated in
the biotech/pharma industry provided disclosure in relation to
COVID-19 that was overly promotional and/or lacked specificity
to fully address the issuer’s business intentions and expected
milestones.</FONT>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLBODY>
            </SGMLTBL>
          </TMPTABLE>
        </BLOCK2>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Please refer to</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Appendix A – Key Observations and Disclosure Considerations –</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">for more detail
regarding the significant issues identified in our reviews and disclosure guidance. Please refer to</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Appendix B – Disclosure Examples</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">where we have included some examples of deficient disclosure
contrasted against improved entity-specific disclosure. The observations and disclosure considerations
presented do not represent an exhaustive list and do not represent all the requirements that could apply to
a particular issuer’s situation. Issuers should consider their specific business and operations and provide
clear and transparent disclosure of the impact of COVID-19.</FONT>
        </P>
      </BLOCK1>
      <BLOCK1>
        <TI>Appendix A – Key Observations and Disclosure Considerations</TI>
      </BLOCK1>
      <BLOCK1>
        <TI>A.1 MD&amp;A Reporting</TI>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">MD&amp;A is the cornerstone of a reporting issuer’s overall financial disclosure and should provide an
analytical and balanced discussion of the issuer’s results of operations and financial condition through the
eyes of management. MD&amp;A disclosure should be specific, useful and understandable. The MD&amp;A
requirements are set out in Form 51-102F1</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>Management’s Discussion and Analysis</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">(</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Form 51-102F1</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">).</FONT>
        </P>
        <P>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">Some of the observations and considerations below may be relevant for issuers that prepare an annual
information form (</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">AIF</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">) with reference to Form 51-102F2</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>Annual Information Form</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">(</FONT>
          <BOLD>
            <FONT font-name="TimesNewRomanPS-BoldMT" font-size="11.00pt">Form 51-102F2</FONT>
          </BOLD>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">).
Specifically, issuers should consider additional disclosure for COVID-19 under Item 4-</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>General
Development of the Business</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">and Item 5-</FONT>
          <FONT font-name="TimesNewRomanPS-ItalicMT" font-size="11.00pt">
            <EM>Describe the Business</EM>
          </FONT>
          <FONT font-name="TimesNewRomanPSMT" font-size="11.00pt">of Form 51-102F2.</FONT>
        </P>
        <BLOCK2 LABEL="Table">
          <TMPTABLE>
            <SGMLTBL>
              <TBLHEAD TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="19" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="35" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="46" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Focus Area</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Observations</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="3">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Considerations</FONT>
                      </BOLD>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLHEAD>
              <TBLBODY TBLWD="600">
                <TBLCDEFS COLSEP="VSINGLE" HALIGN="CENTER" CHARPOS="75%" TOPSEP="HSINGLE">
                  <TBLCDEF COLWD="19" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="35" TBLUNITS="PERCENT" />
                  <TBLCDEF COLWD="46" TBLUNITS="PERCENT" />
                </TBLCDEFS>
                <TBLROWS ROWSEP="HSINGLE" VALIGN="TOP" LEFTSEP="VSINGLE">
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">General: Discussion
of Operational
Status</FONT>
                      </BOLD>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Some issuers provided detailed
operational updates in press
releases but included limited
disclosure in MD&amp;A filings.</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Useful disclosure observed:</FONT>
                      </BOLD>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Many affected issuers significantly
expanded their MD&amp;A to explain
the impact of COVID-19 to the
issuer’s industry, operations,
customers, suppliers etc. Several
issuers disclosed industry and
relevant operational information to
help users frame and understand
the effects on the issuer’s financial
results.</FONT>
                    </TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="3">
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Provide a detailed and transparent discussion
on how COVID-19 has altered the issuer’s
industry and day to day operations. Insight
should be provided into the issuer’s current
operating status and the operational challenges
that management is monitoring. This will vary
materially by issuer and by industry.
 MD&amp;A is a standalone document. Material
operational updates should be reflected in
MD&amp;A filings to provide additional context for
analyzing financial results. Having a separate
“COVID-19” section in the MD&amp;A preceding
the discussion of financial results may provide
a useful framework in understanding the
issuer’s analysis of financial performance,
financial condition and liquidity.</FONT>
                    </TBLCELL>
                  </TBLROW>
                  <TBLROW>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="1"></TBLCELL>
                    <TBLCELL ROWSEP="HSINGLE" COLSTART="2">
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Issuers should consider:</FONT>
                      </BOLD>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Impact of health and safety guidelines on
operations and on how the issuer conducts its
business</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">How the current environment has altered
demand or ability to provide products and
services (both adversely and positively)</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Details of operational closures and restrictions</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Providing information to understand the impact
of shutdowns and closures</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Disclosing relevant industry data that assists
with understanding restrictions and other
impacts to the issuer’s business</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Discussing how customers and suppliers have
been impacted and the effect on the issuer</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Providing a discussion for each segment or
geographic location to the extent operations are
impacted differently</FONT>
                      <FONT font-name="Calibri" font-size="10.00pt">•</FONT>
                      <FONT font-name="TimesNewRomanPSMT" font-size="10.00pt">Explaining how industry and economic factors
have uniquely impacted the issuer</FONT>
                      <BOLD>
                        <FONT font-name="TimesNewRomanPS-BoldMT" font-size="10.00pt">Reference: Part 1, Item 1.2, Item 1.4 of Form 51-</FONT>
                      </BOLD>
                    </TBLCELL>
                  </TBLROW>
                </TBLROWS>
              </TBLBODY>
            </SGMLTBL>
          </TMPTABLE>
        </BLOCK2>
      </BLOCK1>
    </FREEFORM>
  </POLIDOC>
</ROOT>